Current Affairs - Technology - Discussion

The CipAir app, launched by Cipla, is a specialized tool for asthma screening. It uses innovative exhalation tests to assess a user's likelihood of having asthma, categorizing the results into Red, Yellow, or Green zones to indicate varying levels of risk. This helps individuals take timely action by consulting healthcare professionals if necessary. The app is a significant step toward addressing the widespread issue of asthma underdiagnosis in India, where many cases go unnoticed. By facilitating early detection, CipAir contributes to improved asthma management, better patient outcomes, and a reduced burden on the healthcare system.